GeoVax
Blood & Organ Banks · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1955 Lake Park Dr SE Ste 300, Smyrna, Ge...Phone Number
(678) 384-7220Website
www.geovax.comRevenue
-Stock Symbol
GOVXIndustry
About GeoVax
GeoVax Labs, Inc. is a clinical-stage biotechnology company headquartered in the Smyrna, Georgia metropolitan area. The company develops vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers using its proprietary Modified Vaccinia Ankara vector platform. Its priority program, GEO-MVA, targets mpox and smallpox, while its pipeline also includes a next-generation COVID-19 vaccine, a gene-directed therapy for head and neck cancer, and preclinical candidates for Ebola, Marburg, Lassa fever, Zika, and malaria.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: GOVXShow moreGeoVax Org Chart
Compare Similar Companies to GeoVax
Compare insights from companies similar to GeoVax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
GeoVax Tech Stack
A closer look at the technologies used by GeoVax
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GeoVax
Sign Up For FreeTo access detailed company insights
GeoVax Labs, Inc. is a clinical-stage biotechnology company headquartered in the Smyrna, Georgia metropolitan area. The company develops vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers using its proprietary Modified Vaccinia Ankara vector platform. Its priority program, GEO-MVA, targets mpox and... Read More

